IP Library Granted Patent US 12,465,421
Granted Patent B2
US 12,465,421 · App. 18/309,202 · Granted Nov 11, 2025

Multiple treatment zone ablation probe

Inventors: Kevin L. Moss (Fremont, CA); Robert M. Pearson (San Jose, CA)
Assignee: AngioDynamics, Inc.
A61B18/18A61B18/1477A61B18/1487A61B18/1815A61B2018/00029A61B2018/00083A61B2018/00273A61B2018/00529A61B2018/00577A61B2018/00589A61B2018/00613A61B2018/1467A61B2018/1475A61B2090/036
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,465,421
App. No.
18/309,202
Granted
Nov 11, 2025
Kind
B2
Abstract

An energy delivery probe and method of using the energy delivery probe to treat a patient is provided herein. The energy delivery probe has at least one probe body having a longitudinal axis and at least a first trocar and a second trocar. Each trocar comprises at least two electrodes that are electrically insulated from each other, and each electrode is independently selectively activatable. An insulative sleeve is positioned in a coaxially surrounding relationship to each of the first trocar and the second Vocal’. The probe also has a switching means for independently activating at least one electrode. The method involves independently and selectively activating the first and second electrodes to form an ablation zone, then repeating the ablation by delivering energy to a second set of electrodes, producing one or more overlapping ablation zone, and eliminating the need to reposition the ablation probes.

Claims (28)

1 . A method of treating prostate tissue in a patient, the method comprising:

independently positioning and spacing a first electrode and second electrode at a treatment site such that the prostate tissue is disposed at least partially between the first and second electrodes;

wherein each of the first electrode and the second electrode is independently selectively activatable; and

activating an electrical energy source operatively coupled to the first electrode and the second electrode to deliver pulsed electrical energy from the first electrode to the second electrode to generate a first irreversible electroporation zone at least partially within the prostate tissue and to switch activation of the first electrode and the second electrode to deliver pulsed electrical energy from the second electrode to the first electrode to generate a second irreversible electroporation zone at least partially within the prostate tissue.

2 . The method of claim 1 , further comprising:

inserting a trocar into or near the target tissue and coaxially placing an energy delivery probe comprising the first electrode through the trocar.

3 . The method of claim 2 , wherein the trocar comprises a needle tip.

4 . The method of claim 1 , wherein the electrical energy comprises biphasic pulses.

5 . The method of claim 1 , wherein the delivering of electrical energy from the first electrode to the second electrode includes delivering a first set of pulses from the first electrode to the second electrode, wherein the first set of pulses is less than a total number of desired pulses to be delivered from the first electrode to the second electrode.

6 . The method of claim 5 , wherein the delivering of electrical energy from the second electrode to the first electrode includes delivering a second set of pulses from the second monopolar electrode to the first electrode, and wherein the second set of pulses is less than a total number of desired pulses to be delivered from the second electrode to the first electrode.

7 . The method of claim 6 , further comprising repeating switching delivering electrical energy from the first electrode to the second electrode and from the second electrode to the first electrode until the total number of desired pulses to be delivered from the first electrode to the second electrode and from the second electrode to the first electrode is delivered.

8 . The method of claim 6 , wherein the first set and second set of electrical pulses each include 10 electrical pulses.

9 . The method of claim 8 , wherein first set and second set of electrical pulses are delivered such that there is a delay between the first set and second set of electrical pulses.

10 . The method of claim 1 , wherein the positioning of the first electrode near the target tissue comprises positioning a first probe near the target tissue, the first probe including the first electrode and an insulator coaxially surrounding the first probe; and wherein the positioning of the second electrode near the target tissue comprises positioning a second probe near the target tissue, the second probe including the second electrode and an insulator coaxially surrounding the second probe.

11 . The method of claim 1 , wherein activating the electrical energy source operatively coupled to the first electrode and the second electrode comprises repeating alternating of delivery of pulsed electrical energy from the first electrode to the second electrode to generate the first irreversible electroporation zone at least partially within the prostate tissue and delivery of pulsed electrical energy from the second electrode to the first electrode to generate the second irreversible electroporation zone at least partially within the prostate tissue.

12 . A system for treating soft tissue in a patient, the system comprising:

a first energy delivery probe comprising a first electrode;

a second electrode configured to be independently placed near the soft tissue in a spaced relation relative to the first energy delivery probe, wherein each of the first electrode and the second electrode are independently selectively activatable; and

an electrical energy source configured to be operatively coupled to the first electrode and the second electrode, the electrical energy source being configured to switch activation of the first electrode and the second electrode to cause the electrical energy source to deliver electrical energy from the first electrode to the second electrode to generate a first non-thermal ablation zone and to cause the electrical energy source to deliver electrical energy from the second electrode to the first electrode to generate a second non-thermal ablation zone that at least partially overlaps the first non-thermal ablation zone,

wherein the electrical energy source is configured to deliver a first set of pulses from the first electrode to the second electrode, and wherein the first set of pulses is less than a total number of desired pulses to be delivered from the first electrode to the second electrode.

13 . The system of claim 12 , wherein the second electrode is on a second energy delivery probe.

14 . The system of claim 12 , further comprising an insulator coaxially surrounding the first energy delivery probe.

15 . The system of claim 12 , wherein the electrical energy source is programmed to deliver biphasic electrical pulses or monophasic electrical pulses.

16 . The system of claim 12 , wherein the delivering of electrical energy from the second electrode to the first electrode includes delivering a second set of pulses from the second electrode to the first electrode, and wherein the second set of pulses is less than a total number of desired pulses to be delivered from the second electrode to the first electrode.

17 . The system of claim 16 , wherein the electrical energy source is configured to repeat switching from delivering electrical energy from the first electrode to the second electrode and from the second electrode to the first electrode until the total number of desired pulses to be delivered from the first electrode to the second electrode and from the second electrode to the first electrode is delivered.

18 . The system of claim 16 , wherein the first set and second set of electrical pulses each include 10 electrical pulses.

19 . The system of claim 14 , wherein the soft tissue comprises prostate tissue.

20 . The system of claim 12 , wherein the electrical energy source is configured to deliver a second set of pulses from the second electrode to the first electrode, and wherein the second set of pulses is less than a total number of desired pulses to be delivered from the second electrode to the first electrode.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2023
From: MOSS, KEVIN L.; PEARSON, ROBERT M.
To: ANGIODYNAMICS, INC.
Reel/Frame 063482/0187 →
Continuity (8)
Continuation 16912883 · Jun 26, 2020
Continuation 15985006 · May 21, 2018
Continuation 15613366 · Jun 5, 2017
Continuation 14989061 · Jan 6, 2016
Continuation 14733115 · Jun 8, 2015
Continuation 13630135 · Sep 28, 2012
Provisional Application 61540190 · Sep 28, 2011
Related Publication 20230263570A1 · Aug 24, 2023
References Cited (139)
US 5749914A · Janssen · 1998 [cited by applicant]
US 5759158A · Swanson · 1998 [cited by applicant]
US 5983140A · Smith · 1999 [cited by applicant]
US 6009647A · Feingold · 2000 [cited by applicant]
US 6010616A · Lewis et al. · 2000 [cited by applicant]
US 6033402A · Tu · 2000 [cited by applicant]
US 6055456A · Gerber · 2000 [cited by applicant]
US 6135999A · Fanton et al. · 2000 [cited by applicant]
US 6796981B2 · Wham et al. · 2004 [cited by applicant]
US 7395112B2 · Keisari et al. · 2008 [cited by applicant]
US 7871406B2 · Nields et al. · 2011 [cited by applicant]
US 8055323B2 · Sawyer · 2011 [cited by applicant]
US 8403925B2 · Miller · 2013 [cited by applicant]
US 8670816B2 · Green · 2014 [cited by applicant]
US 9700368B2 · Callas · 2017 [cited by applicant]
US 10905492B2 · Neal, II · 2021 [cited by applicant]
US 11607271B2 · Garcia · 2023 [cited by applicant]
US 11607537B2 · Latouche · 2023 [cited by applicant]
US 11638603B2 · Sano · 2023 [cited by applicant]
US 11655466B2 · Neal, II · 2023 [cited by applicant]
US 11723710B2 · Neal, II · 2023 [cited by applicant]
US 11737810B2 · Davalos · 2023 [cited by applicant]
US 11890046B2 · Neal · 2024 [cited by applicant]
US 11903690B2 · Davalos · 2024 [cited by applicant]
US 11925405B2 · Davalos · 2024 [cited by applicant]
US 11950835B2 · O'Brien · 2024 [cited by applicant]
US 11952568B2 · Neal, II · 2024 [cited by applicant]
US 11974800B2 · Sano · 2024 [cited by applicant]
US 12059197B2 · Davalos · 2024 [cited by applicant]
US 12173280B2 · Neal, II · 2024 [cited by applicant]
US 12214189B2 · Lorenzo · 2025 [cited by applicant]
US 12232792B2 · Neal · 2025 [cited by applicant]
US 20010043706A1 · Masuda · 2001 [cited by applicant]
US 20040116935A1 · Lechot · 2004 [cited by applicant]
US 20040237340A1 · Rembrandt · 2004 [cited by applicant]
US 20050004567A1 · Daniel · 2005 [cited by applicant]
US 20050063974A1 · Reinhard · 2005 [cited by applicant]
US 20060111705A1 · Janzen · 2006 [cited by applicant]
US 20060234752A1 · Mese · 2006 [cited by applicant]
US 20070016125A1 · Wong · 2007 [cited by applicant]
US 20070129720A1 · Demarais · 2007 [cited by applicant]
US 20070153135A1 · Han · 2007 [cited by applicant]
US 20070203537A1 · Goetz · 2007 [cited by applicant]
US 20080009102A1 · Yang · 2008 [cited by applicant]
US 20080125775A1 · Morris · 2008 [cited by applicant]
US 20080172104A1 · Kieval · 2008 [cited by applicant]
US 20080183256A1 · Keacher · 2008 [cited by applicant]
US 20080319511A1 · Pless · 2008 [cited by applicant]
US 20090326346A1 · Kracker · 2009 [cited by applicant]
US 20100152725A1 · Pearson · 2010 [cited by examiner]
US 20100160906A1 · Jarrard · 2010 [cited by examiner]
US 20100191235A1 · Moshe · 2010 [cited by examiner]
US 20100222377A1 · Crooks · 2010 [cited by applicant]
US 20110064371A1 · Leatherman · 2011 [cited by applicant]
US 20110190851A1 · Kelly · 2011 [cited by applicant]
US 20110238057A1 · Moss · 2011 [cited by applicant]
US 20120090643A1 · Bertsch · 2012 [cited by applicant]
US 20120136347A1 · Brustad · 2012 [cited by applicant]
US 20120139734A1 · Olde · 2012 [cited by applicant]
US 20120220998A1 · Long · 2012 [cited by applicant]
US 20120265183A1 · Tulleken · 2012 [cited by applicant]
US 20120265194A1 · Podhajsky · 2012 [cited by applicant]
US 20130023871A1 · Collins · 2013 [cited by applicant]
US 20130033977A1 · Lin · 2013 [cited by applicant]
US 20130090346A1 · Johns · 2013 [cited by applicant]
US 20130110103A1 · Assmus · 2013 [cited by applicant]
US 20130296908A1 · Schulte · 2013 [cited by applicant]
US 20130338761A1 · Plowiecki · 2013 [cited by applicant]
US 20140276748A1 · Ku · 2014 [cited by applicant]
US 20150134584A1 · Nakagawa · 2015 [cited by applicant]
US 20160058493A1 · Neal, II · 2016 [cited by applicant]
US 20160143398A1 · Kim · 2016 [cited by applicant]
US 20160310203A1 · Gaspredes · 2016 [cited by applicant]
US 20160337310A1 · Faccin · 2016 [cited by applicant]
US 20170086713A1 · Pushpala · 2017 [cited by applicant]
US 20170209218A1 · Sahay · 2017 [cited by applicant]
US 20170360323A1 · Li · 2017 [cited by applicant]
US 20180028260A1 · Onik · 2018 [cited by applicant]
US 20180036529A1 · Jaroszeski · 2018 [cited by applicant]
US 20180132922A1 · Neal, II · 2018 [cited by applicant]
US 20180177543A1 · You · 2018 [cited by applicant]
US 20190023804A1 · Onik · 2019 [cited by applicant]
US 20190117964A1 · Bahrami · 2019 [cited by applicant]
US 20190223936A1 · Otten · 2019 [cited by applicant]
US 20190254736A1 · Wham · 2019 [cited by applicant]
US 20190336757A1 · Rodriguez · 2019 [cited by applicant]
US 20210162210A1 · Altmann · 2021 [cited by applicant]
US 20220362549A1 · Sano · 2022 [cited by applicant]
US 20230157759A1 · Garcia · 2023 [cited by applicant]
US 20230212551A1 · Neal, II · 2023 [cited by applicant]
US 20230248414A1 · Sano · 2023 [cited by applicant]
US 20230355293A1 · Davalos · 2023 [cited by applicant]
US 20230355968A1 · Davalos · 2023 [cited by applicant]
US 20240008911A1 · Davalos · 2024 [cited by applicant]
US 20240074804A1 · Neal · 2024 [cited by applicant]
US 20240173063A1 · Neal, II · 2024 [cited by applicant]
US 20240268878A1 · Davalos · 2024 [cited by applicant]
US 20240277245A1 · Davalos · 2024 [cited by applicant]
US 20240299076A1 · O'Brien · 2024 [cited by applicant]
US 20250000569A1 · Davalos · 2025 [cited by applicant]
DE 833111 · 1952 [cited by applicant]
EP 0528891B1 · 2000 [cited by applicant]
EP 1061983B1 · 2004 [cited by applicant]
EP 0935482B1 · 2005 [cited by applicant]
EP 1406685B1 · 2008 [cited by applicant]
EP 1424970B1 · 2008 [cited by applicant]
JP 4252316A · 2009 [cited by applicant]
JP 2009532077 · 2009 [cited by applicant]
JP 2010503496 · 2010 [cited by applicant]
JP 2012515018 · 2012 [cited by applicant]
WO 2010015592 · 2010 [cited by applicant]
WO 2012140376 · 2012 [cited by applicant]
WO 2023172773A1 · 2023 [cited by applicant]
WO 2024081749A2 · 2024 [cited by applicant]
Duck, F. A., Physical Properties of Tissue: A Comprehensive Reference Book. London: Harcourt Brace Jovanovich, 1990. [cited by applicant]
Gabriel, C, Dielectric properties of biological tissue: variation with age. Bioelectromagnetics, 2005. Suppl 7: p. S12-8. [cited by applicant]
Hasgall, P. et al., “IT'IS Database for thermal and electromagnetic parameters of biological tissues,” 2018, it is.swiss/database%0A%0A. [cited by applicant]
International Search Report for PCT/US2015/065792 mailed Feb. 9, 2016. [cited by applicant]
Nath, S., Dimarco, J. P. and Haines, D. E. (1994), Basic Aspects of Radiofrequency Catheter Ablation. Journal of Cardiovascular Electrophysiology, 5: 863-876. [cited by applicant]
Persichetti F et al, “Normal and Expanded Huntington's Disease Gene Alleles Produce Distinguishable Proteins Due To Translation Across the CAG Repeat”, Molecular Medicine, Feinstein Institute for Medical Research, Washi… [cited by applicant]
Jan Ko et al, “New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins”, Brain Research Bulletin, Elsevier Science LTD, Oxford, GB, (20011001), vol. 56, No. 3-4, doi:… [cited by applicant]
Alberts et al., “Molecular Biology of the Cell,” 3rd edition, Garland Science, New York, 1994, 1 page. [cited by applicant]
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies; J Galon, D Bruni; Nature reviews Drug discovery, 2019 (pp. 1-22). [cited by applicant]
Korohoda, W. et al. “Reversible and Irreversible Electroporation of Cell Suspensions Flowing Through a Localized DC Electric Field”, Cellular & Molecular Biology Letters, vol. 18 (2013), pp. 102-119 (published Dec. 27, … [cited by applicant]
Latouche, E. L., M. B. Sano, M. F. Lorenzo, R. V. Davalos, and R. C. G. Martin, “Irreversible electroporation for the ablation of pancreatic malignancies: A patient-specific methodology,” J. Surg. Oncol., vol. 115, No. … [cited by applicant]
LV, Y. et al. “The Englargement of Ablation Area by Electrolytic Irreversible Electroporation (E-IRE) Using Pulsed Field with Bias DC Field”, Annals of Biomedical Engineering, vol. 50, No. 12, Dec. 2022, 10 pages. [cited by applicant]
Mercadal, Borja et al. “Dynamics of Cell Death After Conventional IRE and H-FIRE Treatments”, Annals of Biomedical Engineering, vol. 48, No. 5, 2020, p. 1451-1462. [cited by applicant]
Neal II et al., “A Case Report on the Successful Treatment of a Large Soft-Tissue Sarcoma with Irreversible Electroporation,” Journal of Clinical Oncology, 29, pp. 1-6, 2011. [cited by applicant]
Notice of Allowance dated Jun. 21, 2024 for U.S. Appl. No. 16/938,778 (pp. 1-10). [cited by applicant]
Notice of Allowance dated Jul. 24, 2024 for U.S. Appl. No. 16/938,778 (pp. 1-2). [cited by applicant]
PCT Application No. PCT/2011/062067, International Preliminary Report on Patentability dated May 28, 2013. 7 pages. [cited by applicant]
PCT Application No. PCT/2011/066239, International Preliminary Report on Patentability dated Jun. 25, 2013. 7 pages. [cited by applicant]
PCT Application No. PCT/US15/30429, International Report on Patentability dated Nov. 15, 2016. 7 pages. [cited by applicant]
PCT Application No. PCT/US19/51731, International Preliminary Report on Patentability dated Mar. 23, 2021, 13 pages. [cited by applicant]
PCT Application No. PCT/US2010/029243, International Search Report, 4 pgs, (Jul. 30, 2010), Written Opinion, 7 pgs, (Jul. 30, 2010), and International Preliminary Report on Patentability, 8 pgs, (Oct. 4, 2011). [cited by applicant]
Pending Application No. PCT/US21/51551, International Search Report and Written Opinion dated Dec. 29, 2021, 14 pages. [cited by applicant]
Pending Application No. PCT/US23/15118, International Search Report and Written Opinion dated Jul. 31, 2023, 18 pages. [cited by applicant]
Pending Application No. PCT/US23/76626, International Search Report and Written Opinion, dated Apr. 17, 2024, 12 pages. [cited by applicant]
Reti, I. M. and Davydow, D. S., “Electroconvulsive Therapy and Antibiotics: A Case Report”, J. Ect, vol. 23, No. 4, Dec. 2007, pp. 289-290. [cited by applicant]